Prevalence and risk factors for chronic endometritis in patients with adenomyosis and infertility: a retrospective cohort study

Background To explore the incidence of chronic endometritis (CE) in patients with infertility and different forms of adenomyosis and analyze potential high-risk factors for infection.

This retrospective cohort study included 154 patients with infertility in the Liuzhou Maternity and Child Healthcare Hospital. Among them, 77 patients with adenomyosis were divided into four subgroups based on magnetic resonance imaging (MRI): internal, exterior, intramural, and full-thickness. Meanwhile, 77 patients did not have adenomyosis. Hysteroscopy and endometrial biopsy were performed in the proliferative phase. The main outcome measures were the morphology of the endometrium, syndecan-1 (CD138) immunohistochemical staining, clinical characteristics, and prevalence of CE in the adenomyosis subgroups.

In comparison to the non-adenomyosis group, the adenomyosis group had significantly higher body mass index (BMI) and CA125 levels. The menstrual cycle in the adenomyosis group was significantly shorter, and menarche was significantly earlier. In comparison to the non-adenomyosis group, the adenomyosis group had a significantly higher diagnostic rate of CE (75.3% vs. 46.8% according to hysteroscopy and 74.0% vs. 33.8% according to histopathology, both with p < .050). The incidence of CE was significantly lower in patients with internal adenomyosis when compared with the other three subgroups. Increased BMI contributed to a higher risk of CE.

The prevalence of CE was significantly higher in patients with adenomyosis and infertility. The differences in the incidence of CE are closely associated with the classification of adenomyosis. When patients with infertility are diagnosed with adenomyosis, it is recommended to identify the subtype and screen for endometritis. Summary The prevalence of CE in patients with adenomyosis and infertility is significantly higher and differences in the incidence of CE are closely associated with the classification of adenomyosis.

Adenomyosis, CD138, Chronic endometritis, Hysteroscopy, Infertility Prevalence and risk factors for chronic endometritis in patients with adenomyosis and infertility: a retrospective cohort study Jingjing Li1†, Jiajia Wei1†, Saiqiong Chen1, Xindan Wang1, Jing Chen1, Dingyuan Zeng1 and Li Fan1* Page 2 of 8 Li et al. BMC Women's Health (2024) 24:403

Chronic endometritis (CE) is a type of endometrial inflammation characterized by plasma cell incursion into the endometrial matrix region [ 1]. Although CE is frequently silent or presents as non-specific clini - cal symptoms such as abnormal uterine bleeding, pelvic discomfort, leukorrhea, and minor gastrointestinal dis - comfort, it may cause decreased fertility and impede the implantation of embryos [ 2– 5]. Women who are infertile and have a history of endometriosis, recurrent pregnancy loss (RPL), and repeated implantation failure (RIF) are at a higher risk of developing CE. Recently, the incidence rate of CE is 14–42% in cases of RIF and 27–57.8% in cases of RPL [ 6]. Traditionally, CE is diagnosed by endo - metrial sample histopathology analysis, hysteroscopy, and microbiological culture. Plasma cell identification through histological analysis of endometrial biopsies is the gold standard for diagnosis [ 7, 8]. Emerging evidence suggest that no fewer than five plasma cells for each high- power field (HPF) could accurately characterize a CE diagnosis with important clinical ramifications [9, 10]. Adenomyosis refers to pathological changes result - ing in the thickening of the inner myometrium, while the endometrium is proliferative. The incidence of this disease in women at childbearing age ranges from 20 to 25% [11– 13]. Over 50% of patients experience abnormal hemorrhage, pelvic pain, and fertility problems [ 5, 6, 14]. Adenomyosis is an occasionally chronic, immuno- inflammatory illness, involving multiple inflammatory factors, including TNF-α in the focal tissues, IL-1β, IL-6, and IL-8 [ 15]. A multicenter cohort study conducted in Japan reported that patients with diffuse adenomyosis had a greater prevalence of uterine infection; however, the study did not investigate whether these women had concurrent CE [ 16]. Through cross-sectional research, Khan et al. reported that the varying prevalence of CE in various types of adenomyosis could contribute to unfavorable reproductive outcomes [ 17]. Nevertheless, little data is available on the prevalence of CE in adeno - myosis and patients who are infertile. This retrospective study aimed to explore the hysteroscopic characteristics of patients with infertility and adenomyosis combined with CE, and the correlation between CE and infertility in these patients.

Ethical considerations This study was approved by the ethics committee of our institution (No. KS-LS-2023-001). The need for informed consent was waived due to the retrospective nature of the study. Patients We retrospectively reviewed 154 patients with infertil - ity who underwent hysteroscopy procedures at Liuzhou Maternal and Child Health Care Hospital in Guangxi, China, between January 2020 and June 2023. Overall, 77 patients were diagnosed with adenomyosis, and the remaining 77 patients did not have adenomyosis, which was confirmed by histology or imaging. The inclusion criteria included (i) age between 18 and 45 years; (ii) confirmed infertility (unable to conceive after a year of consistent sexual activity without using contraception); (iii) without a contraindication for sur - gery (e.g., serious cardiovascular disease, coagulopathy, or acute reproductive tract infection); and (iv) access to thorough medical information. The exclusion criteria included: (i) history of antibiotic or anti-inflammatory medication use within 3 months before surgery; (ii) history of hysteroscopy within 3 months before surgery; (iii) history of intrauterine adhe - sions; (iv) history of uterine anomalies, submucous myo - mas, endometrial polyps, intrauterine hyperplasia, and endometrial tuberculosis; and (v) diagnosed malignant uterine tumor. As reported previously [ 18], all patients with adeno - myosis underwent 1.5T MRI for evaluation for at least 6 months before hysteroscopic surgery. MRI is consid - ered the gold standard for the noninvasive identification of adenomyosis in patients with infertility [ 19] and can clearly demonstrate the presence of adenomyosis with either symmetric or asymmetric lesions in the internal or exterior layers of the myometrium [20]. The normal junc- tional zone (JZ) is located immediately beneath the endo- metrium and represents the innermost compact layer of the myometrium [ 21]. Patients with adenomyosis may exhibit focal or diffuse JZ hypertrophy. A JZ thickness of 12 mm or greater is the most frequently used threshold for diagnosis of adenomyosis, while a measurement of less than 8  mm has a high negative predictive value for the presence of the disorder [ 22, 23]. Based on the rela - tionship between the adenomyotic lesion, uterine serosa, and endometrium, 77 patients with adenomyosis were classified into four subgroups: internal, exterior, intramu- ral, and full-thickness. Every surgical operation was performed under general anesthesia and by experienced gynecological surgeons. All the surgeries were performed in the follicular phase of the menstrual cycle using a rigid hysteroscope (KMS, Hunan, China). An advancing hysteroscope was used to carefully examine the front and back walls, two flank walls, two sides of the cervix, and cervical mucosa across endometrial surfaces throughout this assessment. This technique allowed for a close inspection of potential mac- roscopic indicators for CE, such as uterine cavity mor - phology, intima thickness, color, elasticity, smoothness, Page 3 of 8 Li et al. BMC Women's Health (2024) 24:403 glands, stroma, and oviductal orifice [ 24]. Discrete or widespread micropolyps, stromal edema, and generalized periglandular hyperemia were the signs observed dur - ing hysteroscopy to identify CE [ 25– 27]. An endometrial biopsy was performed at the end of the procedure. The formalin-fixed biopsy samples were sent to the Depart - ment of Pathology for a histological assessment. The presence of at least five plasma cells in the endometrial stroma per ten HPF confirmed a CE diagnosis following an immunohistochemistry (IHC) labeling using a CD138 antibody [9, 10]. Statistical analysis Statistical analysis and graphical representations were performed using SPSS 26.0 (SPSS Inc., Chicago, IL). Nor - mal distribution data are displayed as mean ± SD, whereas skewed distribution data are displayed as median and interquartile range. To contrast different grouping vari - ables, one-way analysis of variance or the Kruskal-Wallis test was performed. To ascertain the distinctions among subgroups, a post-hoc test was carried out when there was a significant difference. Count data are reported as percentages (%), and the chi-square test or Fisher’s exact test was carried out. Subgroup differences were con - firmed using a post-hoc Bonferroni test when there was a significant difference. Univariate and multivariate logis- tic regression analyses were performed to examine the factors influencing CE. Statistical significance was set at p < .050.

Clinical parameters A total of 77 patients were assigned to the cohort with adenomyosis, while another 77 cases were assigned to the cohort without adenomyosis. Table  1 presents the research population’s demographic characteristics. No statistically significant differences in the length of infer - tility, infertility history, time of pregnancy, abortion, and delivery, anti-Müllerian hormone (AMH) levels, or the presence of hydrosalpinx were observed between the two groups. Considerable variations were observed in age at menarche, length of menstrual cycle, body mass index (BMI), and CA125 levels across both cohorts. In com - parison to the non-adenomyosis group, the adenomyosis group had significantly higher BMI and CA125 levels, although the menstrual cycle was significantly shorter and the age at menarche was significantly lower (Table 1). Hysteroscopic features and CD138 immunohistochemical staining Compared with the non-adenomyosis group, the adeno - myosis group had a higher diagnostic rate of CE (75.3% vs. 46.8% according to hysteroscopy and 74.0% vs. 33.8% according to histopathology, both p < .050). Each hys - teroscopic feature associated with CE was analyzed individually. In patients with adenomyosis, the primary manifestation linked to a hysteroscopic diagnosis of CE was the presence of micropolyps, while in patients with - out adenomyosis, it was hyperemia. Micropolyps were detected in 51.7% of cases in the adenomyosis cohort and 27.8% in the non-adenomyosis cohort, indicating a considerably higher incidence of micropolyps in the adenomyosis group ( p < .050). The prevalence of edema, hyperplasia, or hyperemia did not significantly differ between the two cohorts (Table 2). Additionally, the inci- dence of CE in patients with internal adenomyosis was significantly lower than in the other three types, as deter - mined by hysteroscopy or histopathology (Table 3). Logistic regression analysis of variables affecting CE in patients with adenomyosis Based on histopathology, the 77 patients with adenomyo- sis were divided into two groups: 20 without CE (non-CE group) and 57 with CE (CE group). The risk variables for CE were investigated using univariate logistic regres - sion analysis. No significant correlation was observed between patient age, AMH level, pregnancy frequency, presence of endometriosis, presence of hydrosalpinx, history of uterine cavity surgery, or lesion number or Table 1 Clinical characteristics of patients (AM and non-AM cohorts) Variable AM cohort(n = 77) Non-AM cohort(n = 77) P value Age(years) 36.0(32.5, 39.0) 36.0(33.0, 39.5) 0.500 Age of menarche 12.0(11.0,12.0) 13.0(12.0,13.0) 0.000 menstrual cycle(days) 28.0(26.3,29.0) 29.0(28.0,30.0) 0.000 BMI (kg/m2) 26.8(24.7,30.4) 25.5(23.7,27.9) 0.017 Length of infertility(years) 4.0(3.0,5.5) 4.0(2.0,6.0) 0.339 Infertility 0.164 Primary infertility(%) 36.4%(28/77) 26.0%(20/77) Secondary infertility(%) 63.6%(49/77) 74.0%(57/77) Pregnancy(n) 1.0(0.0,3.0) 1.0(0.0,3.0) 0.453 Abortion(n) 1.0(0.0,3.0) 1.0(0.0,3.0) 0.562 Delivery(n) 0.0(0.0,1.0) 0.0(0.0,1.0) 0.185 AMH(ng/ml) 2.7(2.0,3.9) 2.7(2.2,3.7) 0.533 CA125(U/ml) 39.0(0.35.0,50.0) 15.0(9.5,20.0) 0.000 Presence of hydrosalpinx(%) 48.1%(37/77) 33.8%(26/77) 0.071 Table 2 The diagnosis of CE based on hysteroscopy and histopathology (AM and non-AM cohorts) Variable AM cohort(n = 77) Non- AM cohort(n = 77) P value Hysteroscopy(+)(%) 75.3%(58/77) 46.8%(36/77) 0.000 Hyperemic(%) 36.2%(21/58) 47.2%(17/36) 0.290 Micropolyps(%) 51.7%(30/58) 27.8%(10/36) 0.022 Edema hyperplasia(%) 34.5%(20/58) 38.9%(14/36) 0.667 CD138 IHC(+)(%) 74.0%(57/77) 33.8%(26/77) 0.000 Page 4 of 8 Li et al. BMC Women's Health (2024) 24:403 location. However, notable distinctions were observed between the CE and non-CE groups regarding patient BMI, CA125 levels, frequency of abortions, and adeno - myosis type (internal vs. full-thickness). We evaluated the associations between BMI, CA125 levels, abortion frequency, adenomyosis type, and CE predisposing factors to validate the findings of the uni - variate logistic regression analysis. Compared to patients with internal adenomyosis, those with full-thickness ade - nomyosis had a significantly higher CE rate (Table 4). Using receiver operating characteristic (ROC) curves, we examined the connection between BMI and CE rates. Based on the information, BMI had the highest Youden Index (26.07) for age. Our findings showed that patients’ CE rates were significantly higher in those with a BMI > 26.07 kg/m2 (Fig. 1).

This study compared the uterine cavity conditions of patients with and without adenomyosis and confirmed the presence of endometritis through histopathologi - cal and immunohistochemical analyses. Adenomyosis is being discovered in infertile women more frequently as a result of the current tendency of women delaying pregnancy until their late thirties or early forties [ 13]. Previous studies have suggested that multiple parity is a protective factor against adenomyosis, whereas a short menstruation cycle, early age of menarche, history of depression, and increased BMI are considered promoting factors [ 28– 30]. Our study found that the BMI and CA125 levels were significantly higher in the adenomyo - sis cohort than in the non-adenomyosis cohort. However, the age at menarche was significantly lower, and the men- strual cycle was significantly shorter, which supports the findings of previous studies. In our opinion, early men - arche can be interpreted as a surrogate indicator of high levels of pro-inflammatory estrogen exposure during development [ 31], and recurrent menstruation-induced impaired spontaneous decidualization could increase the likelihood of adenomyosis development. The exact mechanism behind the correlation between infertility and adenomyosis remains elusive. Neverthe - less, several hypotheses have been proposed to address this association, including altered endometrial function/ receptivity, impairment of utero-tubal sperm transport, menstrual cycle disruption, local inflammation trig - gered by adenomyosis, and dysregulation of local hor - mone metabolism, culminating in a hyperestrogenic local environment [ 32]. The incidence of CE brought on by intrauterine microbial infections may be linked to poor reproductive outcomes in women with adenomyo - sis [17]. Several recent investigations have demonstrated that women with and without adenomyosis have distinct vaginal microbiota patterns [33]. Notably, adenomyosis is associated with a distinctive endometrial microbiota pro- file, with certain pathogenic bacteria such as Citrobacter freundii, Prevotella copri, and Burkholderia cepacia being implicated [34]. The activation of cytokines that promote Table 3 Comparison of incidence of CE in patients with different types of adenomyosis Parameter Internal(n = 25) External(n = 17) Intramural(n = 10) Full-thickness(n = 25) P Hysteroscopy(+)(%) 56.0%(14/25)a 76.5%(13/17) 100%(10/10) 84.0%(21/25) 0.026 CD138 IHC(+)(%) 48.0%(12/25)a 82.4%(14/17) 90.0%(9/10) 88.0%(22/25) 0.006 Notes: a. Indicates a significant difference between patients with internal adenomyosis and patients with external, intramural, and full-thickness adenomyosis (p < .05). Table 4 Univarlate and multivariate logistic regresslon analysis of factors influencing CE Variable Univariate logistic OR (95%CI) P Multivariate logistic OR (95%CI) P Age(years) 1.036 0.541 - - BMI (kg/m2) 1.594 0.000 1.535 0.007 AMH(ng/ml) 1.017 0.944 - - CA125(U/ml) 1.090 0.011 1.087 0.093 Pregnancy frequency 0.796 0.072 - - Abortion frequency 0.718 0.021 0.660 0.053 Presence of endometriosis 0.549 0.280 - - Presence of hydrosalpinx积水 0.847 0.751 - - History of uterine cavity surgery frequency 0.830 0.171 - - Type of adenomyosis (vs. Full-thickness) Internal 0.128 0.007 0.116 0.030 External 0.192 0.039 0.375 0.315 Intramural 0.635 0.643 0.149 0.126 Location of lesions(vs. Fundus) Anterior 1.038 0.954 - - Posterior 0.677 0.551 - - Page 5 of 8 Li et al. BMC Women's Health (2024) 24:403 inflammation, coupled with the production of virulence factors by specific endometrial microbiota, subsequently influences various cellular processes, including inflam - mation, immunoregulation, survival, proliferation, inva - sion, and angiogenesis of endometrial cells. [ 35– 37]. Based on available data, the association between adeno - myosis and poor reproductive outcomes may be attrib - uted to the destruction of the microvillus and axonemal alteration within the apical endometrium due to endo - metrial inflammation [ 38]. Currently, CE diagnosis is based on the results of endometrial biopsy and hystero - scopic examination. Despite having limited participants, our study provides a deeper understanding of the preva - lence of endometritis in patients with adenomyosis and infertility. Our findings demonstrated that compared to the non-adenomyosis group, the adenomyosis group had a significantly higher prevalence of CE. According to Khan et al., women with adenomyosis had a higher inci - dence of CE (about 60%) than those with uterine myo - mas (10%) [ 17]. In contrast, both cohort groups showed a higher prevalence of CE, confirming high prevalence of CE in low-fertility population. However, there was a lack of consensus between histological and hysteroscopic findings in each investigation (with agreement ranging from 46.5 to 95% for CE diagnosis or exclusion) (34). Even in instances where hysteroscopic indications of CE are present, confirmation through endometrial biopsy and histological analysis remains imperative. Histology remains the gold standard diagnostic approach owing to discrepancies frequently observed between hysteroscopy and histopathology outcomes among patients. Conse - quently, relying solely on positive hysteroscopic findings without histological verification may lead to erroneous CE diagnoses, potentially resulting in overdiagnosis [39]. Our results also showed that the main presentation of a hysteroscopic diagnosis of CE in patients with adeno - myosis was micropolyps, whereas that in the non-adeno - myosis group was hyperemia. Micropolyps are recently discovered tiny intrauterine growths < 1  mm in size and have a unique connective vascular axis that can be found across the endometrial surface or in specific loca - tions [26]. The histological examination of the connective axis of micropolyps reveals the presence of inflamma - tory cell accumulation; furthermore, it is proposed that Fig. 1 Receiver operating characteristic curves Page 6 of 8 Li et al. BMC Women's Health (2024) 24:403 micropolyps signify an endometrial proliferative stimulus owing to an increased level of inflammation [ 26, 27]. It is speculated that the appearance of micropolyp features may be related to changes in endometrial receptors in patients with adenomyosis. Estrogen receptor expres - sion increases with an increase in inflammation, whereas progesterone receptor expression decreases in the bor - der area, inducing progesterone resistance [ 40], damag - ing endometrial health, and leading to local tissue edema and proliferation. However, the specific pathological and physiological changes require further exploration. Based on the findings of previous studies, the differ - ent subtypes may represent heterogeneous etiologies and pathogenesis. Intrinsic adenomyosis may occur when the endometrium traverses directly into the inner and medial myometrium. External adenomyosis may occur as a consequence of direct invasion of the serosa by extrauterine endometriosis. Intramural adenomyosis may be caused by metaplasia or epithelial-mesenchymal transition (EMT). A diverse combination of different types of advanced disease may result in full-thickness adenomyosis [ 41]. Prior research [ 18] has established a strong correlation between variations in clinical mani - festation and pregnancy outcomes and the classifica - tion of adenomyosis. Consequently, it is indisputable that diverse treatment approaches and subtype-specific adenomyosis analysis must be considered when analyz - ing the impact of adenomyosis on pregnancy outcomes. In this study, patients with internal adenomyosis had the lowest incidence of CE. Additionally, the incidence of CE was found to be influenced by the type of adenomyosis, as indicated by the multivariate logistic regression analy - sis. Compared with patients with internal adenomyosis, those with full-thickness adenomyosis had a significantly higher CE rate. As adenomyotic lesions progress and become stiffer due to increased fibrosis, pro-fibrotic mol- ecules originating from the lesions migrate toward the adjacent endometrial-myometrial interface [ 42]. EMT and fibroblast-to-myofibroblast trans-differentiation are facilitated by macrophage-secreted inflammatory cytokines and growth factors, which ultimately result in lesion invasion and fibrosis [43]. The pain associated with adenomyosis was found to be positively correlated with the quantity of accumulated macrophages [ 44]. Based on our previous findings, patients with full-thickness ade - nomyosis experienced more menstrual discomfort than those with internal adenomyosis [ 18]. Combining the above mechanisms and clinical manifestations may help explain this phenomenon. Conversely, Khan et al. discov- ered that intrinsic adenomyosis had a considerably higher tissue infiltration of macrophages in the endometria than extrinsic adenomyosis. However, a lack of substantial dif- ferentiation in the incidence of CE was seen between the two adenomyosis types. Similarly, in endometria from women with various forms of adenomyosis, there were no appreciable variations in the location of CD138-stained plasma cells [ 17]. The endometrial regions and phases of the menstrual cycle of the samples may account for these variations. Epithelial cells derived from the secre - tory phase endometrium of adenomyotic uteri exhibited decreased levels of pro-inflammatory cytokines in vitro. This finding may indicate that stromal cells present in adenomyosis lesions, specifically during the proliferative phase, play a significant role in mediating the locally dys - regulated immunological reaction [ 45]. Incidence of CE was found to be considerably higher on the homolateral side compared to the contralateral side in patients with localized adenomyosis [ 17]. All our research samples were in the proliferative phase, but there were no spe - cific endometrial regions. This study offers an exhaustive foundation for subsequent investigations in this field. Women with uncontrolled endometrial inflamma - tion are prone to developing adenomyosis, the central component of uterine adenomyotic lesions. However, the causal relationship between adenomyosis and CE remains unclear, and a comprehensive assessment of its effects on female fertility is required. Using univari - ate and multivariate analyses, we investigated the fac - tors that contribute to CE in patients with adenomyosis and infertility. Multiple logistic regression analysis find - ings indicated that BMI influences the incidence of CE in addition to adenomyosis type. One case-control study showed that overweight or obese women had a higher risk of developing adenomyosis [ 46]. Women diagnosed with adenomyosis were more prone to central obesity and had reduced levels of high-density lipoprotein C, according to recent research examining the individual components of metabolic syndrome [ 47]. In a study on polycystic ovary syndrome (PCOS), it was found that obesity increases both hyperandrogenism and low-grade inflammation in patients with PCOS [ 48]. The degree of obesity has a major impact on the reproductive system in women. Increased endometrial levels of free fatty acids can negatively impact endometrial function in obese PCOS patients [ 49]. Weight loss is a well-known ele - ment in restoring endometrial function [ 50]. Our study revealed a significantly higher CE incidence in patients with a BMI > 26.07 kg/m2 based on ROC curves, and we hypothesized that BMI may have a predictive role in the CE incidence rate in adenomyosis, and weight loss may reduce the incidence of adenomyosis and CE. However, more studies on metabolic risk factors related to adeno - myosis must be conducted to confirm this hypothesis. The design of this study had some limitations. First, the study examined patients’ observations from a single loca- tion and was restricted to certain types of samples. Future research should consider different menstrual cycle stages, and endometrial regions of the uterine cavity should be Page 7 of 8 Li et al. BMC Women's Health (2024) 24:403 distinguished and detected during sampling. Second, hysteroscopy and endometrial biopsy were performed by different physicians, possibly introducing heterogene - ity. Our current research has opened new directions for exploring the exact mechanism and causal relationship between CE and adenomyosis, as well as their impact on fertility outcomes. Further research using larger sample sizes and more comprehensive data is required to vali - date the correlation between CE and adenomyosis in patients with infertility.

We retrospectively studied incidence of CE in patients with infertility with different forms of adenomyosis and attempted to explore the related high-risk factors. The prevalence of CE is significantly higher in patients with adenomyosis and infertility. The differences in the inci - dence of CE are closely associated with the classification of adenomyosis. When patients with infertility are diag - nosed with adenomyosis, it is recommended to clarify the classification and screen for endometritis. Further research is required to explore the mechanisms underly - ing these effects. Abbreviations CE chronic endometritis MRI magnetic resonance imaging BMI body mass index RPL recurrent pregnancy loss RIF repeated implantation failure HPF High-power field IHC immunohistochemistry AMH anti-Müllerian hormone ROC receiver operating characteristic EMT epithelial-mesenchymal transition PCOS polycystic ovary syndrome

Not applicable. Author contributions Dingyuan Zeng and Li Fan designed the study. Jingjing Li and Jiajia Wei contributed to data collection, data analysis, and writing the manuscript. Both Jingjing Li and Jiajia Wei contributed equally to this study. Saiqiong Chen and Jing Chen contributed to data collection. Saiqiong Chen, Xindan Wang, and Jing Chen performed the surgical procedures. All authors reviewed the manuscript and approved the final version of the manuscript for publication. Funding This study was funded by the Guangxi Science and Technology Plan Project under a Grant from the Guangxi Clinical Research Center for Obstetrics and Gynecology (Grant No. GuiKe AD22035223), and the Key Research and Development Program of Guangxi (Grant No. Guike AB18126056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data availability The datasets used and/or analysed during the current study available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was approved by the Ethics Committee of Liuzhou Maternal and Child Health Care Hospital (Ethics No. KS-LS-2023-001). Written informed consent was obtained from all subjects. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Received: 23 March 2024 / Accepted: 4 July 2024

1. Michels TC. Chronic endometritis. Am Family Phys. 1995;52(1):217–22. 2. Bayer-Garner IB, Nickell JA, Korourian S. Routine syndecan-1 immunohisto- chemistry aids in the diagnosis of chronic endometritis. Arch Pathol Lab Med. 2004;128(9):1000–3. 3. Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2010;93(2):437–41. 4. Vitagliano A, Saccardi C, Noventa M, Di Spiezio Sardo A, Saccone G, Cicinelli E, Pizzi S, Andrisani A, Litta PS. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: a systematic review and meta-analysis. Fertil Steril. 2018;110(1):103–e112101. 5. Morimune A, Kimura F, Moritani S, Tsuji S, Katusra D, Hoshiyama T, Nakamura A, Kitazawa J, Hanada T, Amano T, et al. The association between chronic deciduitis and preeclampsia. J Reprod Immunol. 2022;150:103474. 6. Zolghadri J, Momtahan M, Aminian K, Ghaffarpasand F, Tavana Z. The value of hysteroscopy in diagnosis of chronic endometritis in patients with unex- plained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):217–20. 7. Song D, Li TC, Zhang Y, Feng X, Xia E, Huang X, Xiao Y. Correlation between hysteroscopy findings and chronic endometritis. Fertil Steril. 2019;111(4):772–9. 8. Kasius JC, Broekmans FJ, Sie-Go DM, Bourgain C, Eijkemans MJ, Fauser BC, Devroey P , Fatemi HM. The reliability of the histological diagnosis of endome- tritis in asymptomatic IVF cases: a multicenter observer study. Hum Reprod (Oxford England). 2012;27(1):153–8. 9. Li Y, Xu S, Yu S, Huang C, Lin S, Chen W, Mo M, Lian R, Diao L, Ding L, et al. Diagnosis of chronic endometritis: how many CD138 + cells/HPF in endome- trial stroma affect pregnancy outcome of infertile women? Am J Reproduc- tive Immunol (New York NY: 1989). 2021;85(5):e13369. 10. Xiong Y, Chen Q, Chen C, Tan J, Wang Z, Gu F, Xu Y. Impact of oral antibiotic treatment for chronic endometritis on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women: a cohort study of 640 embryo transfer cycles. Fertil Steril. 2021;116(2):413–21. 11. Szubert M, Koziróg E, Olszak O, Krygier-Kurz K, Kazmierczak J, Wilczynski J. Adenomyosis and infertility-review of Medical and Surgical approaches. Int J Environ Res Public Health. 2021;18(3). 12. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Research. 2019; 8. 13. Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G, Taniguchi F. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv. 2016;71(9):557–68. 14. Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-Patho- genesis, diagnosis, and management. Best Pract Res Clin Obstet Gynecol. 2017;40:68–81. 15. Bourdon M, Santulli P , Jeljeli M, Vannuccini S, Marcellin L, Doridot L, Petraglia F, Batteux F, Chapron C. Immunological changes associated with adenomyo- sis: a systematic review. Hum Reprod Update. 2021;27(1):108–29. 16. Tamura H, Kishi H, Kitade M, Asai-Sato M, Tanaka A, Murakami T, Minegishi T, Sugino N. Complications and outcomes of pregnant women with adeno- myosis in Japan. Reproductive Med Biology. 2017;16(4):330–6. 17. Khan KN, Fujishita A, Ogawa K, Koshiba A, Mori T, Itoh K, Nakashima M, Kitawaki J. Occurrence of chronic endometritis in different types of human adenomyosis. Reproductive Med Biology. 2022;21(1):e12421. Page 8 of 8 Li et al. BMC Women's Health (2024) 24:403 18. Wei J, Wang L, Tao H, Wang X, Zheng F, He P , Zhou L, Fan L, Chen J, Zhong H, et al. Comparison of pregnancy outcomes in infertile patients with different types of adenomyosis treated with high-intensity focused ultrasound. Int J Hyperthermia: Official J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2023;40(1):2238140. 19. Khandeparkar MS, Jalkote S, Panpalia M, Nellore S, Mehta T, Ganesan K, Parikh FR. High-resolution magnetic resonance imaging in the detection of subtle nuances of uterine adenomyosis in infertility. Global Reproductive Health. 2018;3(3):e14. 20. Sudderuddin S, Helbren E, Telesca M, Williamson R, Rockall A. MRI appear- ances of benign uterine disease. Clin Radiol. 2014;69(11):1095–104. 21. Scoutt LM, Flynn SD, Luthringer DJ, McCauley TR, McCarthy SM. Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology. 1991;179(2):403–7. 22. Loring M, Chen TY, Isaacson KB. A systematic review of adenomyosis: it is time to reassess what we thought we knew about the Disease. J Minim Invasive Gynecol. 2021;28(3):644–55. 23. O’Shea A, Figueiredo G, Lee SI. Imaging diagnosis of adenomyosis. Semin Reprod Med. 2020;38(2–03):119–28. 24. Cicinelli E, Trojano G, Mastromauro M, Vimercati A, Marinaccio M, Mitola PC, Resta L, de Ziegler D. Higher prevalence of chronic endometritis in women with endometriosis: a possible etiopathogenetic link. Fertil Steril. 2017;108(2):289–e295281. 25. Bouet PE, El Hachem H, Monceau E, Gariépy G, Kadoch IJ, Sylvestre C. Chronic endometritis in women with recurrent pregnancy loss and recurrent implan- tation failure: prevalence and role of office hysteroscopy and immunohisto- chemistry in diagnosis. Fertil Steril. 2016;105(1):106–10. 26. Cicinelli E, Resta L, Nicoletti R, Zappimbulso V, Tartagni M, Saliani N. Endo- metrial micropolyps at fluid hysteroscopy suggest the existence of chronic endometritis. Hum Reprod (Oxford England). 2005;20(5):1386–9. 27. Cicinelli E, Tinelli R, Lepera A, Pinto V, Fucci M, Resta L. Correspondence between hysteroscopic and histologic findings in women with chronic endometritis. Acta Obstet Gynecol Scand. 2010;89(8):1061–5. 28. Jean-Baptiste H, Tetrokalashvili M, Williams T, Fogel J, Hsu CD. Characteris- tics associated with postoperative diagnosis of adenomyosis or combined adenomyosis with fibroids. Int J Gynaecol Obstet. 2013;122(2):112–4. 29. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A, Reynolds P , Cress R, et al. Adenomyosis and endometriosis in the California teachers Study. Fertil Steril. 2008;90(2):415–24. 30. Shafrir AL, Farland LV, Shah DK, Harris HR, Kvaskoff M, Zondervan K, Missmer SA. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynecol. 2018;51:1–15. 31. Lund CI, Engdahl B, Rosseland LA, Stubhaug A, Grimnes G, Furberg AS, Steingrímsdóttir ÓA, Nielsen CS. The association between age at menarche and chronic pain outcomes in women: the Tromsø Study, 2007 to 2016. Pain. 2022;163(9):1790–9. 32. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med. 2022; 11(14). 33. Kunaseth J, Waiyaput W, Chanchaem P , Sawaswong V, Permpech R, Payung- porn S, Sophonsritsuk A. Vaginal microbiome of women with adenomyosis: a case-control study. PLoS ONE. 2022;17(2):e0263283. 34. Lin Q, Duan H, Wang S, Guo Z, Wang S, Chang Y, Chen C, Shen M, Shou H, Zhou C. Endometrial microbiota in women with and without adenomyosis: a pilot study. Front Microbiol. 2023;14:1075900. 35. Yang Z, Kong B, Mosser DM, Zhang X. TLRs, macrophages, and NK cells: our understandings of their functions in uterus and ovary. Int Immunopharma- col. 2011;11(10):1442–50. 36. Turner ML, Healey GD, Sheldon IM. Immunity and inflammation in the uterus. Reprod Domest Anim = Zuchthygiene. 2012;47(Suppl 4):402–9. 37. Jiang C, Liu C, Guo J, Chen L, Luo N, Qu X, Yang W, Ren Q, Cheng Z. The expression of toll-like receptors in eutopic and ectopic endometrium and its implication in the inflammatory pathogenesis of adenomyosis. Sci Rep. 2017;7(1):7365. 38. Khan KN, Fujishita A, Suematsu T, Ogawa K, Koshiba A, Mori T, Itoh K, Teramukai S, Matsuda K, Nakashima M, et al. An axonemal alteration in apical endometria of human adenomyosis. Hum Reprod (Oxford England). 2021;36(6):1574–89. 39. Moreno I, Cicinelli E, Garcia-Grau I, Gonzalez-Monfort M, Bau D, Vilella F, De Ziegler D, Resta L, Valbuena D, Simon C. The diagnosis of chronic endome- tritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. Am J Obstet Gynecol. 2018;218(6):e602601–16. 40. Squillace ALA, Simonian DS, Allegro MC, Borges E, Bianchi PHM, Bibancos M. Adenomyosis and in vitro fertilization impacts - a literature review. JBRA Assist Reprod. 2021;25(2):303–9. 41. Han X, Gao X, Wang F, Shang C, Liu Z, Guo H. Heterogeneity of clinical symp- toms and therapeutic strategies for different subtypes of adenomyosis: an initial single-center study in China. Int J Gynaecol Obstet. 2023;161(3):775–83. 42. Guo SW. Various types of adenomyosis and endometriosis: in search of optimal management. Fertil Steril. 2023;119(5):711–26. 43. Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44(3):450–62. 44. Orazov MR, Radzinsky VE, Nosenko EN, Khamoshina MB, Dukhin AO, Leb- edeva MG. Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis. Gynecol Endocrinology: Official J Int Soc Gynecol Endocrinol. 2017;33(sup1):44–6. 45. Maclean A, Barzilova V, Patel S, Bates F, Hapangama DK. Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: a systematic review. J Reprod Immunol. 2023;157:103925. 46. Trabert B, Weiss NS, Rudra CB, Scholes D, Holt VL. A case-control investigation of adenomyosis: impact of control group selection on risk factor strength. Women’s Health Issues: Official Publication Jacobs Inst Women’s Health. 2011;21(2):160–4. 47. Ates S, Aydın S, Ozcan P . Cardiometabolic profiles in women with adenomyo- sis. J Obstet Gynaecology: J Inst Obstet Gynecol. 2022;42(7):3080–5. 48. Hu M, Zhang Y, Li X, Cui P , Li J, Brännström M, Shao LR, Billig H. Alterations of endometrial epithelial-mesenchymal transition and MAPK signalling com- ponents in women with PCOS are partially modulated by metformin in vitro. Mol Hum Reprod. 2020;26(5):312–26. 49. Rhee JS, Saben JL, Mayer AL, Schulte MB, Asghar Z, Stephens C, Chi MM, Moley KH. Diet-induced obesity impairs endometrial stromal cell decidualiza- tion: a potential role for impaired autophagy. Hum Reprod (Oxford England). 2016;31(6):1315–26. 50. Palomba S. Is fertility reduced in ovulatory women with polycystic ovary syn- drome? An opinion paper. Hum Reprod (Oxford England). 2021;36(9):2421–8. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.